[go: up one dir, main page]

MX2019005045A - Vacunas de mosaico para virus de la fiebre aftosa serotipo a. - Google Patents

Vacunas de mosaico para virus de la fiebre aftosa serotipo a.

Info

Publication number
MX2019005045A
MX2019005045A MX2019005045A MX2019005045A MX2019005045A MX 2019005045 A MX2019005045 A MX 2019005045A MX 2019005045 A MX2019005045 A MX 2019005045A MX 2019005045 A MX2019005045 A MX 2019005045A MX 2019005045 A MX2019005045 A MX 2019005045A
Authority
MX
Mexico
Prior art keywords
fmdv
mosaic
polypeptides
serotype
mouth disease
Prior art date
Application number
MX2019005045A
Other languages
English (en)
Inventor
E Rieder Aida
m fischer William
K Rai Devendra
Original Assignee
Us Agriculture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Agriculture filed Critical Us Agriculture
Publication of MX2019005045A publication Critical patent/MX2019005045A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se describen polipeptidos mosaico del virus de la fiebre aftosa (FMDV) sinteticos, y moleculas de acido nucleico que codifican los polipeptidos mosaico; los polipeptidos mosaico tiene una mayor cobertura de epitopes de celulas T que los polipeptidos de FMDV que ocurren de manera natural, e incluyen epitopes de FMDV comunes, pero excluyen epitopes de FMDV raros; cuando se incluyen como parte de un genoma de FMDV, los polipeptidos mosaico permiten la replicacion viral y el ensamble en particulas de FMDV; las composiciones de polipeptido mosaico y acido nucleico pueden utilizarse para provocar respuestas inmunes que proporcionan proteccion contra un amplio rango de cepas de FMDV serotipo A.
MX2019005045A 2016-10-31 2017-10-25 Vacunas de mosaico para virus de la fiebre aftosa serotipo a. MX2019005045A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662415124P 2016-10-31 2016-10-31
US15/785,875 US10172933B2 (en) 2016-10-31 2017-10-17 Mosaic vaccines for serotype a foot-and-mouth disease virus
PCT/US2017/058295 WO2018081274A1 (en) 2016-10-31 2017-10-25 Mosaic vaccines for serotype a foot-and-mouth disease virus

Publications (1)

Publication Number Publication Date
MX2019005045A true MX2019005045A (es) 2019-10-14

Family

ID=62020851

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019005045A MX2019005045A (es) 2016-10-31 2017-10-25 Vacunas de mosaico para virus de la fiebre aftosa serotipo a.

Country Status (10)

Country Link
US (1) US10172933B2 (es)
EP (1) EP3532484A4 (es)
JP (1) JP7137276B2 (es)
CN (1) CN110382518B (es)
AU (1) AU2017350853B2 (es)
BR (1) BR112019008584A2 (es)
CA (1) CA3041809A1 (es)
MX (1) MX2019005045A (es)
RU (1) RU2019113940A (es)
WO (1) WO2018081274A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3244920T1 (sl) 2015-01-16 2023-09-29 The United States of America, represented by The Secretary of Agriculture, United States Department of Agriculture Cepivo proti slinavki in parkljevki
US20250134984A1 (en) * 2023-10-26 2025-05-01 The United States Of America, As Represented By The Secretary Of Agriculture Development of mosaic vaccines against foot and mouth disease virus serotype asia

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
CA2194761C (en) 1994-07-15 2006-12-19 Arthur M. Krieg Immunomodulatory oligonucleotides
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
JP2001513776A (ja) 1997-02-28 2001-09-04 ユニバーシティ オブ アイオワ リサーチ ファウンデーション ＬＰＳ関連障害の処置における非メチル化ＣｐＧジヌクレオチドを含む核酸の使用
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
ATE370740T1 (de) 1997-05-20 2007-09-15 Ottawa Health Research Inst Verfahren zur herstellung von nukleinsäurekonstrukten
ATE356630T1 (de) 1998-04-03 2007-04-15 Univ Iowa Res Found Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
CN1408434A (zh) * 2002-09-16 2003-04-09 复旦大学 抗家畜口蹄疫的多肽和dna联合疫苗及其制备方法
US20110014232A1 (en) * 2009-07-16 2011-01-20 Agricultural Research Council Chimeric foot and mouth disease viruses
US9109014B2 (en) * 2009-11-02 2015-08-18 The Trustees Of The University Of Pennsylvania Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
GB201014965D0 (en) 2010-09-08 2010-10-20 Animal Health Inst Vaccine
CN102406929B (zh) * 2011-11-25 2013-09-04 青岛红桥明勤生物科技有限公司 一种共表达分子佐剂加强型二价口蹄疫蛋白工程疫苗
JP2016501850A (ja) 2012-11-16 2016-01-21 ユナイテッド・バイオメディカル・インコーポレーテッドＵｎｉｔｅｄ Ｂｉｏｍｅｄｉｃａｌ Ｉｎｃｏｒｐｏｒａｔｅｄ 口蹄疫（ｆｍｄ）に対する合成ペプチドベースの緊急ワクチン
EP2978448B1 (en) 2013-03-26 2018-05-30 The Pirbright Institute Stabilised fmdv capsids
KR102526219B1 (ko) 2014-09-23 2023-04-26 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 Ｆｍｄｖ 재조합 백신 및 이의 용도

Also Published As

Publication number Publication date
AU2017350853A1 (en) 2019-05-23
AU2017350853B2 (en) 2021-11-25
JP7137276B2 (ja) 2022-09-14
EP3532484A4 (en) 2020-07-01
RU2019113940A (ru) 2020-11-09
CN110382518A (zh) 2019-10-25
CN110382518B (zh) 2022-11-29
US10172933B2 (en) 2019-01-08
RU2019113940A3 (es) 2020-12-21
EP3532484A1 (en) 2019-09-04
CA3041809A1 (en) 2018-05-03
JP2019533465A (ja) 2019-11-21
WO2018081274A1 (en) 2018-05-03
US20180117138A1 (en) 2018-05-03
BR112019008584A2 (pt) 2019-09-17

Similar Documents

Publication Publication Date Title
CO2018005265A2 (es) Vacunas de ácido nucleico para el virus varicela-zóster
CO2018005229A2 (es) Vacuna de virus sincitial respiratorio
PH12017500727A1 (en) Modified virus-like particles of cmv
HK1208355A1 (en) Universal influenza vaccine based on heterologous multiple m2e proteins
MX2015008847A (es) Composiciones inmunogenicas de virus de influenza y usos de las mismas.
MX2017008187A (es) Combinacion de vacuna basada en listeria con anticuerpos anti-ox40 o anti-gitr.
EP4104854A3 (en) Multivalent vaccines for rabies virus and coronaviruses
ZA202403393B (en) Synthetic chimeric poxviruses
WO2017147553A3 (en) Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human flt3l or gm-csf for cancer immunotherapy
WO2014150822A3 (en) Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
NZ630869A (en) Compositions and methods for dengue virus chimeric constructs in vaccines
MX344103B (es) Vacunas de virus herpes vectorizado con virus de enfermedad de newcastle.
MX2019000215A (es) Composiciones inmunogenicas a base de listeria que comprenden antigenos de proteinas del tumor de wilms y metodos para su uso.
MA40228A (fr) Souche de listeria recombinée exprimant des protéines de fusion à antigène hétérologues et procédés pour les utiliser
WO2015195218A8 (en) Polyvalent influenza virus-like particles (vlps) and use as vaccines
FI3220937T3 (fi) Pneumolysiinimutantteja ja menetelmiä niiden käyttämiseksi
MX2017016273A (es) Vacuna contra el virus de la fiebre aftosa (fmdv) de virus vaccinia ankara modificado (mva) recombinante.
NZ751943A (en) Hepatitis c virus immunogenic compositions and methods of use thereof
EA033027B1 (ru) Ослабленные вакцины от свиного гриппа и способы их получения и применения
AR108014A1 (es) Vacuna universal para enfermedades virales y método de vacunación
PH12017500419A1 (en) Recoded arbovirus and vaccines
MX2019005045A (es) Vacunas de mosaico para virus de la fiebre aftosa serotipo a.
MX2019007924A (es) Vacunas contra la influenza.
PH12018501532A1 (en) Cancer vaccines
IN2014DN09445A (es)